| Title： | Guidelines for the diagnosis and treatment of fibromyalgia syndrome |
| Edition： | Original |
| Classification： | Standard guideline |
| Field： | Diagnosis and Treatment |
| Countries and regions： | China |
| Guidelines users： | First-line Chinese medicine doctors, western medicine doctors, rheumatologists in the field of integrated Chinese and Western medicine and professionals related to the diagnosis and treatment of fibromyalgia syndrome. |
| Evidence classification method： | The quality of evidence for the efficacy and safety of traditional Chinese medicine in the treatment of fibromyalgia was evaluated by GRADE method.According to the GRADE method, the quality of evidence is divided into four grades: high, medium, low and very low.Recommendation intensity is divided into: strong recommendation and weak recommendation [6].In the grading process of GRADE evidence quality, five factors were considered, including bias risk, consistency, accuracy, publication bias, and indirection, and three factors were considered, including large effect size, confounding factor bias, and dose effect.Present the evidence through the evidence summary table. |
| Development unit： | The Guang 'anmen Hospital, China Academy of Chinese Medical Sciences |
| Registration time: | 2020-10-21 |
| Registration number： | IPGRP-2020CN160 |
| Purpose of the guideline: | In order to further enhance clinical attention to FMS and guide doctors to conduct standardized management of FMS more effectively, the expert group formulated the Fibromyalgia Syndrome Diagnosis and Treatment Guidelines.This guide only represents the views of the joint consensus group, and has certain reference value to standardize the diagnosis and treatment of integrated Traditional Chinese and Western medicine.The aim is to promote clinicians in rheumatology, pain, psychology, neurology and other relevant departments to attach great importance to the comprehensive management of FMS and the recognition and intervention of early FMS symptoms, early screening, early assessment, early intervention and early treatment, so as to improve the quality of life of patients. |
Latest registration
